3592-25-4

Basic information

• Product Name: 1 5-DICHLORO-3-PENTANONE
• Synonyms: 1 5-DICHLORO-3-PENTANONE;3-PENTANONE, 1,5-DICHLORO- (6CI,7CI,8CI,9CI);3Pentanone1,5Dichloro;Bis(2-chloroethyl) ketone. 2,2-Dichlorodiethyl ketone;1,5-Dichloropentan-3-one
• CAS NO: 3592-25-4
• Molecular Formula: C₅H₈Cl₂O
• Molecular Weight: 155.02242
• Product Categories: API intermediates
• Mol File: 3592-25-4.mol

Chemical Properties

• Boiling Point: 225 °C at 760 mmHg
• Flash Point: 90.6 °C
• Appearance: yellow to light brown liquid
• Density: 1.183 g/cm³
• Vapor Pressure: 0.0884mmHg at 25°C
• Refractive Index: 1.446
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 1 5-DICHLORO-3-PENTANONE(CAS DataBase Reference)
• NIST Chemistry Reference: 1 5-DICHLORO-3-PENTANONE(3592-25-4)
• EPA Substance Registry System: 1 5-DICHLORO-3-PENTANONE(3592-25-4)

Safety Data

• Hazard Codes: Xi,T
• Statements: 25
• Safety Statements: 36-45
• RIDADR: 1993
• HazardClass: 3
• PackingGroup: Ⅲ
• Hazardous Substances Data: 3592-25-4(Hazardous Substances Data)

Usage

InChI:InChI=1/C5H8Cl2O/c6-3-1-5(8)2-4-7/h1-4H2

Upstream product

• 53005-18-8 1,5-dimethoxy-pentan-3-one 
• 1833-53-0 2-(Trimethylsilyloxy)propene 
• 625-36-5 2-chloropropionyl chloride 
• 74-85-1 ethene 
• 7429-90-5 aluminium 

Downstream Products

• 115012-51-6 1-(2-Chlorophenyl)-4,4-dimethoxypiperidine 
• 263008-89-5 1-(4-Chlorophenyl)-4,4-diethoxypiperidine 
• 247034-71-5 tert-butyl (2S)-benzenesulfonylamino-3-[3-methoxy-4-{4-(pyrimidin-2-ylamino)piperidin-1-yl}benzoylamino]propionate 
• 247035-46-7 3-methoxy-4-{4-(pyrimidin-2-ylamino)piperidin-1-yl}benzoic acid 
• 247035-45-6 methyl 3-methoxy-4-{4-(pyrimidin-2-ylamino)piperidin-1-yl}benzoate 
• 568584-57-6 methyl 4-(4-aminopiperidin-1-yl)-3-methoxybenzoate 
• 247035-43-4 4-(4-azido-piperidin-1-yl)-3-methoxy-benzoic acid methyl ester 
• 247035-44-5 methyl 4-{4-(methanesulfonyloxy)piperidin-1-yl}-3-methoxybenzoate 
• 247035-42-3 methyl 4-(4-hydroxypiperidin-1-yl)-3-methoxybenzoate 

Relevant articles and documents

The preparation and structures of several cross-conjugated allenes ("allenic dendralenes")

The cross-conjugated allenes ("allenic dendralenes") 2-allenylbuta-1,3-diene (2), 1,1-divinylallene (3, prepared here as the methyl derivative 49), and 1,1-diallenylethene (4) are prepared either by S N2′-substitution processes from appropriate allenic or acetylenic precursors or by base-catalyzed isomerizations of propargylic substrates. Thermal elimination/isomerization routes to these highly unsaturated hydrocarbons require reaction conditions under which these allenes undergo secondary transformations. The new oligoolefins, the structures of which have been calculated by MP2 methods, are interesting substrates for addition and isomerization reactions. The phenomenon of cross-conjugation is extended to allenes; the resulting oligoolefins are predicted to become useful dienes for multiple-Diels-Alder additions allowing the rapid construction of complex carbon frameworks.

A scalable synthesis of MN-447, an antagonist for integrins αvβ3 and αIIbβ 3

(2S)-Benzeneslfonylamino-3-[3-methoxy-4-{4-(1,4,5,6-tetrahydropyrimidin-2- ylamino)piperidin-1-yl}benzoylamino]propionic acid, MN-447, is a potent antagonist of the integrins αvβ33 and αIIbβ3 Herein, we report a novel synthetic protocol that produces MN-447 in an overall yield of 45%. This protocol, when compared with the original synthetic route for MN-447, is more cost-effective, requires fewer steps, does not require chromatographic purification of intermediates and MN-447, and increases the overall yield by 35%. This report focuses on the synthetic strategies that were developed for this protocol. Now, the large quantities of MN-447 that are needed for preclinical and toxicological studies can be readily obtained.

SYNTHESIS OF CHLORINS AND PHORBINES WITH ENHANCED RED SPECTRAL FEATURES

The present invention provides compounds of the general Formula DI: along with methods of making such compounds, formulations containing the same, and methods of using the same (e.g., in photodynamic therapy, for the production of solar cells, etc.).

Novel double para-phenylenediamines joined by a linker arm substituted with at least one group chosen from hydroxyl, alkoxy, and/or amino groups and method of dyeing keratinous fibers

Disclosed herein is a novel family of double para-phenylenediamines joined by a linker arm comprising at least one substituent chosen from hydroxyl, alkoxy, and/or amino substituents. Also disclosed herein is a dyeing composition comprising, in a medium s

Large-scale synthesis of "Cpep" RNA monomers and their application in automated RNA synthesis

Small interfering RNAs (siRNA) are the latest candidates for oligonucleotide-based therapeutics. Should siRNA be successful in clinical trials, a huge demand for synthetic RNA is anticipated. We believe that 1-(4-chlorophenyl)-4-ethoxypiperidin-4-yl (Cpep

m-SUBSTITUTED BENZOIC ACID DERIVATIVES EXHIBITING INTEGRIN ALPHA-V BETA-3 ANTAGONISM

An object of the present invention is to provide m-substituted benzoic acid derivatives having integrin αvβ3 antagonistic activity. The derivatives according to the present invention are compounds represented by formula (I) or pharmaceutically acceptable salts or solvates thereof, which are useful for the treatment or prevention of cardiovascular diseases, angiogenesis-related diseases, cerebrovascular diseases, cancers and metastasis thereof, immunological diseases, osteopathy and other diseases: wherein A represents an optionally substituted heterocyclic group containing two nitrogen atoms, a bicylic group or the like; D represents a bond, >NR4, >CR5R6, O, S, or -NR4-CR5R6-; X represents CH or N; R7 and R8 represent hydroxyl, alkyl or the like; Q represents >C=O or the like; R9 represents hydrogen, alkyl or the like; J represents a bond or alkylene; R10 represents optionally substituted hydroxyl, amino or the like; R11 represents hydrogen, alkyl or the like; m is 0 to 5; n is 0 to 4; and p and q are each 0 to 3.

Synthesis of 1,5-bis(triphenylphosphonium)pentan-3-ol dichloride and its application to the preparation of 1,7-di(pyridin-3-yl)heptan-4-ol

The preparation of 1,7-di(pyridin-3-yl)-heptan-4-ol (1), an important intermediate in the synthesis of a series of novel cancer multidrug resistance (CMR) chemosensitizers, has been accomplished in high overall yield via the new bis-Wittig reagent 1,5-bis(triphenylphosphonium)pentan-3-ol dichloride (6), that can also be used in the preparation of other members of the class of CMRs.

Stepwise versus direct long-range charge separation in molecular triads

Trifunctional electron donor - donor - acceptor molecules are described in which photoinduced charge separation, D2 - D1 - A* → D2 - D1+ - A- , is followed by a charge migration step D

Process for the synthesis of 1,7-diarly or heteroaryl-heptane-4-ols and new synthetic intermediates

This invention offers a process for the synthesis of a compound of the formula STR1 wherein R' is a phenyl, a substituted phenyl, a heterocyclic aromatic group, a heterocyclic aromatic substituted group, a linear or branched alkyl group, or a cycloalkyl group. The invention also comprises the following compounds of a formula 1' and 2' as useful new synthesis intermediates. STR2 wherein R is a phenyl, a substituted phenyl, an alkyl, a cycloalkyl and X is Cl, Br, I, F, CH3 SO3, p--CH3 --C6 H4 --SO3.

Process for the synthesis of 1,7-diaryl or 1,7-heteroarylheptan-4-ols and synthetic intermediates

This invention offers a process for the synthesis of a compound of the formula wherein R' is a phenyl, a substituted phenyl, a heterocyclic aromatic group, a heterocyclic aromatic substituted group, a linear or branched alkyl group, or a cycloalkyl group. The invention also comprises the following compounds of a formula 1' and 2'as useful new synthesis intermediates. wherein R is a phenyl, a substituted phenyl, an alkyl, a cycloalkyl and X is Cl, Br, I, F, CH3SO3, p-CH3-C6H4-SO3.